Cognition Therapeutics, Inc. (CGTX) CEO Lisa Ricciardi On Q4 2021 Results - Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2021 Earnings Call March 30, 2022 8:00 AM ET

Company Participants

Daniel Kontoh-Boateng - Investor Relations

Lisa Ricciardi - President and Chief Executive Officer

Jim O'Brien - Chief Financial Officer

Tony Caggiano - Chief Medical Officer and Head of R&D

Conference Call Participants

Mayank Mamtani - B. Riley Securities

Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.


00:04 Good morning, ladies and gentlemen, and welcome to Cognition Therapeutics Incorporated Fourth Quarter and Fiscal Year 2021 Earnings Conference Call. My name is Olivia and I will be your conference operator today. This call is being recorded.

00:18 I would now like to turn the presentation over to your speaker host for today's call, Mr. Daniel Kontoh-Boateng, Investor Relations for Cognition Therapeutics. Please proceed.

Daniel Kontoh-Boateng

00:36 Good morning and thank you for participating in Cognition Therapeutics conference call today. With me today are Lisa Ricciardi, President and Chief Executive Officer of Cognition; and Jim O'Brien, Chief Financial Officer of Cognition.

00:49 By now you should have the press release we issued earlier. If not, it is available on the Investor Relations page of our website at We encourage everyone to read this morning's press release as well as Cognition's Annual Report on Form 10-K, which is now filed with the SEC. The company's 10-K report and press release are also available on Cognition's website. In addition, this conference call is being webcast through the company's website and will be archived for 30 days.

01:18 Please note that certain information discussed in the call today

Recommended For You

Comments (1)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.